Small non-coding RNA landscape of extracellular vesicles from a post-traumatic model of equine osteoarthritis.
Authors: Anderson James R, Jacobsen Stine, Walters Marie, Bundgaard Louise, Diendorfer Andreas, Hackl Matthias, Clarke Emily J, James Victoria, Peffers Mandy J
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Researchers used small RNA sequencing to characterise extracellular vesicles (EVs)—tiny membrane-bound particles that facilitate cell-to-cell communication—in plasma and synovial fluid from horses with experimentally induced post-traumatic osteoarthritis, tracking changes across disease progression for the first time. Seven microRNAs (eca-miR-451, eca-miR-25, eca-miR-215, eca-miR-92a, eca-miR-let-7c, eca-miR-486-5p, and eca-miR-23a) and four small nucleolar RNAs showed distinct temporal expression patterns in the synovial fluid and plasma EVs, with bioinformatic analysis suggesting these molecules regulate cell cycle arrest, DNA damage responses, and stem cell differentiation in early disease. The differential expression signatures identified—particularly in synovial fluid—point towards a molecular mechanism whereby the joint attempts to limit inflammatory cell proliferation whilst promoting tissue repair during osteoarthritis onset. These findings establish a foundation for developing non-invasive liquid biomarkers that could enable earlier detection of joint disease before radiographic or clinical signs become apparent, potentially allowing therapeutic intervention during a more responsive window; additionally, the identified microRNAs and snoRNAs represent novel therapeutic targets worthy of further investigation for modulating disease progression.
Read the full abstract on PubMed
Practical Takeaways
- •These extracellular vesicle-derived microRNA signatures may enable earlier detection of osteoarthritis through non-invasive blood or synovial fluid sampling before clinical signs appear
- •Understanding the molecular communication pathways via extracellular vesicles could lead to new therapeutic interventions targeting early osteoarthritis progression
- •These biomarkers could help monitor response to treatment in horses with osteoarthritis, though clinical validation studies are still needed
Key Findings
- •Seven microRNAs (eca-miR-451, eca-miR-25, eca-miR-215, eca-miR-92a, eca-miR-let-7c, eca-miR-486-5p, eca-miR-23a) and four snoRNAs showed differential temporal expression in extracellular vesicles during experimental osteoarthritis progression
- •Early osteoarthritis-related microRNAs in synovial fluid were associated with inhibition of cell cycle, DNA damage, and cell proliferation pathways
- •Plasma and synovial fluid extracellular vesicles demonstrated distinct small non-coding RNA signatures that could serve as novel biomarkers for osteoarthritis progression